CD274 and neoplasm: Anti-PD-1/PD-L1 therapy has been discussed as a potential effective strategy for cancer treatment, and numerous studies have reported the positive expression of PD-L1 in tumor cells as a predictive biomarker for the response to PD-1/PD-L1 blocking therapy[42].